Načítá se...
Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β
Platelet-derived growth factor (PDGF) has been implicated in the pathobiology of vascular remodeling. The multikinase inhibitor imatinib that targets PDGF receptor (PDGFR), c-kit and Abl kinases, shows therapeutic efficacy against experimental pulmonary hypertension (PH); however, the role of PDGFR-...
Uloženo v:
Hlavní autoři: | , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Medknow Publications
2011
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3198653/ https://ncbi.nlm.nih.gov/pubmed/22034611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2045-8932.83448 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|